Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial
William S. Weintraub(Unknown), Koon Teo(Population Health Research Institute), John A. Spertus(Saint Luke's Health System), Pamela Hartigan(Department of Veterans Affairs), Christi Deaton(University of Cambridge), Cheryl Lewis(United States Nuclear Regulatory Commission), Ron Goeree(Programs for Assessment of Technology in Health Research Institute), Paul Kolm(Christiana Care Health System), Sandra B. Dunbar(Emory University), Stan Kaufman, Paul G. Barnett(Veterans Health Administration), Paul Casperson(South Texas Veterans Health Care System), William E. Boden(VA New England Healthcare System), Elizabeth M. Mahoney(Emory University), Gordon Blackhouse(McMaster University), Bernard O’Brien(McMaster University), Robert A. O’Rourke(Richard Wolf (Germany)), Edmund R. Becker(Emory University), Robert F. Nease(Express Scripts Holding Company (United States)), Emir Veledar(University of Miami), Shuo Chen(Guangdong Academy of Medical Sciences), Steven D. Culler(Emory University)
Cited by 26
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k